13856 research outputs found
Sort by
人工涙液の組成物
No full text[[abstract]]PROBLEM TO BE SOLVED: To provide artificial-tear compositions having a moisture retention effect, as well as an anti-inflammation and antioxidation effect.SOLUTION: The invention provides an artificial-tear composition containing an agent having an anti-inflammatory and antioxidative effect, an agent which can improve stickiness of liquid, and an artificial-tear. The artificial-tear composition not only has a moisture retention effect, and anti-inflammatory and antioxidative effect, but can extend the residence time of the artificial-tear on the eyeball surface to effectively shorten the number of times in using an eye drop at multiple times or treatment processes of xerophthalmia.SELECTED DRAWING: Non
[[alternative]]Magnetic cell carrier combined with powerless bioreactor system to cell amplification kit
No full text[[abstract]]本創作提供一種具磁性之生物載體結合無動力生物反應器之系統，其包含一生物載體、一無動力生物反應器及一磁場裝置。生物載體能透過溫度的調節使細胞脫離，且能被磁場裝置吸附，以穩定在鵝頸細胞培養槽底部；無動力生物反應器包括一微量輸液元件、一培養液收集元件及一鵝頸細胞培養槽；鵝頸細胞培養槽內部空間與所述微量輸液元件及所述培養液收集元件相互連通，微量輸液元件緩慢注入新鮮培養液至鵝頸管細胞培養槽，當鵝頸管細胞培養槽內培養液高於一溢流位置時，即能藉由連通管原理自動將細胞代謝物排至培養液收集元件，減少細胞受污染的風險。The present invention provide a magnetic cell biocarrier combined with powerless bioreactor system comprising a biocarrier, a powerless bioreactor, and a magnetic field device. The biocarrier is able to detach the cells through temperature regulation and can be adsorbed by the magnetic field device to stabilize at the bottom of the gooseneck cell culture tank; the powerless bioreactor comprises a microinfusion element, a culture fluid collection element and a gooseneck cell culture tank; the internal space of the gooseneck cell culture tank is interconnected with the microinfusion element and the culture fluid collection element, the microinfusion element slowly injects fresh culture medium When the culture medium in the gooseneck cell culture tank is above an overflow position, the cell metabolites can be automatically discharged to the culture fluid collection element by the interconnected vessels to reduce the risk of cell contamination
Mesoporous silica nanoparticles for oil absorption
No full text[[abstract]]Compositions comprising an effective amount of mesoporous silica nanoparticles (MSNs) for use in prevention and/or treatment of steatorrhea in a subject in need thereof are disclosed. Also disclosed are compositions for use in exposing a liquid lipid to MSNs and causing the liquid lipid to gel and/or solidify, or compositions for use in exposing a liquid dietary lipid inside intestines of a subject to the MSNs and causing the liquid dietary lipid to gel and/or solidify inside the intestines of the subject, or compositions for use in reducing intestinal absorption of the liquid dietary lipid
[[alternative]]Caged platinum nanoclusters for anticancer chemotherapeutics
No full text[[abstract]]본 발명은 케이지된 백금 나노클러스터 착물에 관한 것이다. 상기 착물은 (a) 아민-말단화된 덴드리머; 및 (b) 산화백금을 포함하고 상기 아민-말단화된 덴드리머 내부에 국한되어 있는 백금 나노클러스터를 포함한다. 상기 착물은 암 세포에 대해 세포독성을 나타낸다. 이중-케이지된 백금 나노클러스터 착물이 또한 기재되어 있고, 이는 덴드리머 케이지된 백금 나노클러스터 착물의 표면상에 피복된 폴리에틸렌 글리콜(PEG)을 포함한다. 상기 이중-케이지된 백금 나노클러스터 착물은 이의 표면상에 pH-민감성 결합을 포함한다. 또한, 본 발명은 상기 착물을 제조하고 사용하는 방법에 관한 것이다
Magnetic resonance imaging system
No full text[[abstract]]A magnetic resonance imaging system to be used over a target area of a subject includes first and second RF coils for receiving an RF signal from the subject. The first RF coil is fixed to a position device and movable over the target area of subject. The second RF coil is larger than the first RF coil and has a larger field of view than the first RF coil. The system further includes an image processing device programmed to process RF signals coupled from the first RF coil and the second RF coil to form an MRI image
Vorrichtung und Verfahren zum Digitalisieren von PET-Strahlungs-Ereignissen
No full text[[abstract]]A digitization apparatus has comparator (204) which corresponds to the analog pulse channel number to accept the gate (206), amplifier (208), adder circuit (210), analog/digital converter (212) the non-zero selector (214) and the analyzer (216). The analog voltage pulse is produced from the radiation event accepted from the input terminals (202). An independent claim is also included for a digital positron emission tomography (PET) apparatus
[[alternative]]Earplug device for evaluating sleep quality and improving sleep quality
No full text[[abstract]]本新型係以最少干擾睡眠的耳塞式裝置，以配戴在耳內之方式以擷取耳道內溫度、心率、呼吸、血氧飽和濃度、血壓、經脈血流分配概況、移動偵測及/或姿態感測等生理訊號，經過數值計算與分析，從心率變異分析來評估睡眠中腦部神經的運作情況，從呼吸次數及深度、血氧飽和濃度、血壓與姿態變化來監視身體在睡眠中的反應情況；且依據該些生理參數運算出睡眠品質評估資料；並令耳塞式裝置的喇叭在耳道內產生音樂或特定頻率的合成聲音，以刺激腦部調整自律神經系統；及/或令耳塞式裝置的彩色發光二極體模組在耳道內產生特定合成色光以刺激耳道附近對光敏感的腦部細胞以調整腦細胞活性，藉以改善配戴者的睡眠品質
Method and composition for treating hepatocellular carcinoma without viral infection by controlling the lipid homeostasis
No full text[[abstract]]The present invention relates to a method and a pharmaceutical composition for treating an HCC negative for HBV/HCV, comprising administering a subject in need thereof an therapeutically effective amount of an inhibitory agent to control the genetic alteration of lipid homeostasis associated genes, including CD36 amplification and ABCG4 deletion. According to the present invention, medicines targeting the lipid metabolism pathways are developed to treat HCC patients with CD36 amplification and/or ABCG4 deletion
[[alternative]]Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
No full text[[abstract]]本發明係關於一種用於減低K他命(ketamine)之致精神病狀副作用，並增強K他命之抗憂鬱功效的方法。特徵在於利用K他命與甲基甘胺酸衍生物組合進行投藥。本發明亦關於一種用於憂鬱症治療之方法，包含將K他命與甲基甘胺酸衍生物組合進行投藥。本發明進一步提供一種預防或治療K他命之成癮疾患的方法，包含投藥一種甲基甘胺酸衍生物
Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
No full text[[abstract]]The present invention relates to a method for decreasing the psychotomimetic side effects and enhancing the antidepressant-like effects of ketamine by the combination of ketamine with a methyl glycine derivative. The present invention also relates to a method for depression treatment comprising administrating ketamine combined with a methyl glycine derivative. The present invention further provides a method for preventing or treating addictive disorders of ketamine by administrating a methyl glycine derivative